This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Winkle, R. A. Articles by Harrison, D. C. Search for Related Content PubMed PubMed Citation Articles by Winkle, R. A. Articles by Harrison, D. C.

Circulation, Vol 57, 1008-1016, Copyright © 1978 by American Heart Association

ARTICLES

Long-term tocainide therapy for ventricular arrhythmias

RA Winkle, PJ Meffin and DC Harrison

Long-term tocainide therapy has been evaluated in 17 patients with ventricular arrhythmias. Ventricular tachycardia and/or fibrillation was recurrent and sustained in nine patients, and symptomatic but unsustained in three others. Five patients had frequent but only mildly symptomatic ventricular irritability. In all patients, arrhythmias could not be managed with quinidine, procainamide or propranolol. Tocainide doses ranged from 300 to 700 mg every 8 hours (mean steady- state plasma concentrations ranged from 5.75 to 12.18 microgram/ml). Tocainide therapy was unsuccessful in eight patients; three died during therapy and five had no antiarrhythmic response. The data suggest that evaluation of long-term drug efficacy, using the criterion of reduction of asymptomatic arrhythmias, is best documented by multiple sequential ambulatory electrocardiographic recordings, both on and off the drug. Tocainide controlled arrhythmias in nine patients (53%), with criteria of success being continued reduction of ectopic beats and/or control of symptomatic recurrences. Seven patients remain on therapy. Side effects generally have been minor and well-tolerated.

This article has been cited by other articles:

				R. K. Mahapatra and D. Mahapatra Efficacy and Safety of Oral Tocainide in Refractory Ventricular Arrhythmia: A Preliminary Report on an Open Label Study Angiology, April 1, 1986; 37(4): 285 - 293. [Abstract] [PDF]

				G. M. PERLOW, B. P. JAIN, S. G. PAUKER, H. S. ZARREN, D. C. WISTRAN, and R. L. EPSTEIN Tocainide-Associated Interstitial Pneumonitis Ann Intern Med, April 1, 1981; 94(4_Part_1): 489 - 490. [Abstract] [PDF]

				R. A. WINKLE Measuring Antiarrhythmic Drug Efficacy by Suppression of Asymptomatic Ventricular Arrhythmias Ann Intern Med, September 1, 1979; 91(3): 480 - 482. [Abstract] [PDF]